NHS data chief says Palantir-built Federated Data Platform is delivering “outstanding results” as she pushes deeper rollout

What the memo reportedly says

It has been reported that Ming Tang, the NHS’s director of data, described the Palantir-built Federated Data Platform (FDP) as delivering “outstanding results” in an internal memo and urged a wider rollout of the technology across the health service. The memo, according to reporting, frames the FDP as a tool that can federate clinical and operational data without centralising patient records — a pitch designed to allay privacy worries while speeding up analytics and decision-making.

Why this matters

Why does this feel like a pivot? Because the NHS is wrestling with twin pressures: the need for faster, smarter use of data to improve patient care and the public’s deep sensitivity about who handles private health information. It has been reported that Tang argued the FDP could unlock clinical insights and operational efficiencies at scale. For policymakers and clinicians, that promise is seductive. For campaigners and some MPs, it raises familiar red flags about transparency, procurement and long-term vendor lock-in.

Pushback, politics and the bigger picture

Palantir’s involvement ramps up scrutiny. The company is a polarising player — praised for rapid, mission-focused deployments and criticised for opaque contracts and government ties. It has been reported that senior NHS figures want to move faster; watchdogs and privacy advocates want clearer guardrails. The emotional heart of the story is this tension: eager clinicians envision better care, while sceptics fear an outsized private influence over public health data. Which side wins will help shape how Britain — and other countries — balance innovation with oversight in a post-pandemic rush to digitise healthcare.

Sources: ft.com